Malignant Prostate Neoplasm — Trials

Malignant Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,979 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,377
Recruiting: 744
Ph III recruiting: 79
Growth YoY: +22.4%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.1%
Trials / 1,000 deaths: 40.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (730)

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01444820	Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate	active not recruiting	Phase 3	329	Sir Mortimer B. Davis - Jewish General HospitalOTHER	1	Dec 4, 2024	clinicaltrials
NCT01957436	A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer(PEACE1)	active not recruiting	Phase 3	1,173	UNICANCEROTHER	7	Nov 12, 2024